Delivery Device Continues To Be Intarcia’s Downfall Ahead Of FDA Panel On Nonapproval of Implantable GLP-1
Mode of delivery was meant to be a selling point but instead is one of Intarcia’s ITCA 650’s biggest challenges to FDA approval • Source: Shutterstock 
